findmyKOL
Clinical trialNCT03155997Active, not recruitingPhase 3Interventional

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer

SponsorEli Lilly and CompanyEnrollment5,637Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)

    Eli Lilly and Company

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

619 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Centro de Oncologia E Investigacion Buenos Aires

    Berazategui, Buenos Aires, Argentina

  • Instituto de Investigaciones Clinicas Mar del Plata

    Mar del Plata, Buenos Aires, Argentina

  • Hospital Universitario Austral

    Pilar, Buenos Aires, Argentina

  • Hospital Aleman

    Buenos Aires, Buenos Aires F.D., Argentina

  • Fundacion Cenit Para la Investigacion En Neurociencias

    CABA, Ciudad Autonoma Buenos Aires, Argentina

  • Clinica Viedma

    Viedma, Río Negro Province, Argentina

  • Instituto de Oncologia de Rosario

    Rosario, Santa Fe Province, Argentina

  • Centro Para la Atención Integral del Paciente Oncologico (caipo)

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Idim - Instituto de Diagnóstico E Investigaciones Metabólicas

    Buenos Aires, Argentina

  • Instituto Alexander Fleming

    Buenos Aires, Argentina

  • Clinica Adventista de Belgrano

    Ciudad Autonoma Buenos Aires, Argentina

  • Fundación Cori Para la Investigación Y Prevención del Cáncer

    La Rioja, Argentina

  • Consultorio Dr. Miguel Ángel Escudero

    Salta, Argentina

  • Cer San Juan

    San Juan, Argentina

  • Centro Medico San Roque

    San Miguel de Tucumán, Argentina

Australia
  • Chris O'Brien Lifehouse

    Camperdown, New South Wales, Australia

  • St Vincent'S Hospital

    Darlinghurst, New South Wales, Australia

  • Lismore Base Hospital

    Lismore, New South Wales, Australia

  • Liverpool Hospital

    Liverpool, New South Wales, Australia

  • Mater Hospital Sydney

    Sydney, New South Wales, Australia

  • Calvary Mater Newcastle

    Waratah, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Southern Medical Day Care Centre

    Wollongong, New South Wales, Australia

  • Mater Misericordiae Limited

    Brisbane, Queensland, Australia

  • Gold Coast University Hospital

    Southport, Queensland, Australia

  • the Townsville Hospital

    Townsville, Queensland, Australia

  • Lyell Mcewin Hospital

    Elizabeth Vale, South Australia, Australia

  • Ashford Cancer Centre Research

    Kurralta Park, South Australia, Australia

  • Launceston General Hospital

    Launceston, Tasmania, Australia

  • Box Hill Hospital

    Box Hill, Victoria, Australia

  • Epworth Hospital

    East Melbourne, Victoria, Australia

  • Maroondah Hospital

    Melbourne, Victoria, Australia

  • Peter Maccallum Cancer Centre

    Melbourne, Victoria, Australia

  • Breast Cancer Research Centre Wa

    Nedlands, Western Australia, Australia

  • St John of God Subiaco Hospital

    Subiaco, Western Australia, Australia

Austria
  • Klinik Hietzing

    Vienna, State of Vienna, Austria

  • Medizinische Universität Wien

    Vienna, State of Vienna, Austria

  • Universitaetsklinikum Allgemeines Krankenhaus Wien

    Vienna, State of Vienna, Austria

  • Medizinische Universität Graz

    Graz, Styria, Austria

  • Medizinische Universitaet Innsbruck

    Innsbruck, Tyrol, Austria

579 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Jul 2017
Primary completion
16 Mar 2020
Completion
31 May 2029
Last update posted
24 Apr 2026
Registered enrollment
5,637
Registry id
NCT03155997

Cross-registrations

EU-CTR / CTIS (EudraCT)2016-004362-26

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.